Caricamento...
Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease
Alzheimer’s disease (AD) affects more than twenty-five million people worldwide and is the most common form of dementia. Symptomatic treatments have been developed, but effective intervention to alter disease progression is needed. Targets have been identified for disease-modifying drugs, but the re...
Salvato in:
| Pubblicato in: | J Neural Transm |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4305447/ https://ncbi.nlm.nih.gov/pubmed/22354745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00702-012-0772-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|